NewAnswers MCP: one question, one checked answer for your agent.See how it works

Guides

Mass tort vs class action: the difference, where MDLs fit, and how each one pays

By , founder of HyperresearchPublished

A class action is one lawsuit under Federal Rule of Civil Procedure 23 in which one or a few representatives sue for everyone in a defined class, and one judgment or settlement binds every member who does not opt out. A mass tort is many separate injury lawsuits against the same defendant over the same product or event. Each plaintiff keeps their own case, their own proof of injury and their own damages. In federal court those cases are often gathered before one judge in a multidistrict litigation (MDL) under 28 U.S.C. 1407, but only for pretrial work. On September 30, 2025, about 45% of all pending federal civil cases sat in MDLs.

This page explains both, where MDLs fit, how each kind of case settles and pays, and what the court records show. It is not legal advice. If you have a claim, talk to a lawyer licensed in your state.

Mass tort vs class action at a glance

A class action turns many claims into one case; a mass tort keeps them as many cases that move together for a while.

Class action Mass tort MDL
Governing rule FRCP Rule 23 State tort law, case by case; aggregated by MDL, consolidation or bankruptcy 28 U.S.C. 1407
Who is a party One or a few named representatives sue for all class members Every injured person files their own case Any civil cases with a common question of fact, from different districts
Damages Set for the class, then divided under a plan the court approves Each plaintiff proves their own injury and damages Not decided by the MDL itself; it is a pretrial stage
Settlement Binds the class only with court approval after a fairness hearing (Rule 23(e)) Case by case, or in a group settlement that values each claim by injury and evidence Most cases end in the MDL court; the statute sends unresolved cases back to their home courts
Opting out Allowed in Rule 23(b)(3) damages classes; members must ask to be excluded Not needed: you are only in if you file Not an opt-out device; transfer is ordered by the Judicial Panel on Multidistrict Litigation

An MDL is not a third kind of claim. It is a court procedure that can hold mass tort cases, class actions, or both. Of the 158 MDLs pending on September 30, 2025, 107 contained class action allegations, according to the Judicial Panel on Multidistrict Litigation (JPML).

What a mass tort is

A mass tort is a large group of injury or property-damage lawsuits that come from the same product or event. The Federal Judicial Center’s Manual for Complex Litigation, Fourth says the claims “must arise out of an identifiable event or product, affecting a very large number of people and causing a large number of lawsuits.” There is no fixed size. The Manual notes that some put the threshold at 10,000 claims and others at 100 suits, and says the real question is whether the group “calls for special management.”

Two features set mass torts apart:

  • Each case stays individual. The Manual says mass torts mix issues that suit group handling, such as the history of a product’s design, with issues that need individual proof, such as “the circumstances of individual exposure, causation, and damages.”
  • State law usually governs. The Manual says “State substantive law usually governs mass tort cases,” which makes nationwide grouping harder.

The Manual separates two kinds. Single-incident mass torts include “a hotel fire, the collapse of a structure, the crash of a commercial airliner.” Dispersed mass torts “typically arise from widespread use of, or exposures to, widely distributed products or substances, often over an extended time,” such as a drug or a medical device. Some dispersed injuries are latent and take decades to appear.

What a class action is

A class action is a lawsuit in which “one or more members of a class may sue or be sued as representative parties on behalf of all members,” under Rule 23(a). The court must first certify the class. Rule 23(a) allows that only if:

  • the class is “so numerous that joinder of all members is impracticable”;
  • there are “questions of law or fact common to the class”;
  • the representatives’ claims are “typical” of the class; and
  • the representatives “will fairly and adequately protect the interests of the class.”

Most money-damages classes are certified under Rule 23(b)(3). That needs two more findings: common questions “predominate over any questions affecting only individual members,” and a class action is “superior to other available methods” of deciding the dispute.

That predominance test is why personal-injury mass torts rarely become class actions. The Manual for Complex Litigation says “Mass tort personal injury cases are rarely appropriate for class certification for trial,” because “individual issues of causation and individual damages often predominate and state law often varies.” The Manual adds that claims can be different when each one is small: if the amount in each claim is too low, individual suits “may not be a superior, or even feasible, alternative.”

Who gets paid and how

In a class action, the court approves both the total and the way it is divided; in a mass tort, each plaintiff’s payment is tied to their own case.

Class action. A settlement that binds the class needs the court’s approval “after a hearing and only on finding that it is fair, reasonable, and adequate,” under Rule 23(e)(2). The court must weigh “the effectiveness of any proposed method of distributing relief to the class,” the proposed attorney’s fees, and whether the deal “treats class members equitably relative to each other.” Class counsel’s fees are set by the court: Rule 23(h) lets it “award reasonable attorney’s fees and nontaxable costs.” Depending on the settlement, members either file a claim form or are paid directly. In the FTC’s study of 149 consumer settlements, settlements that required every member to file a claim made up the majority of the sample.

Mass tort. Each plaintiff has their own lawsuit, so each plaintiff’s recovery depends on their own injury and proof. The Manual for Complex Litigation notes that parties can resolve claims “through a series of case-by-case, party-by-party settlements,” or seek a global settlement. A group settlement typically values each claim by injury and evidence, as described in the settlement section below.

Where MDLs fit

An MDL is a federal procedure that moves related cases from many districts to one judge for “coordinated or consolidated pretrial proceedings,” under 28 U.S.C. 1407(a). The JPML orders a transfer when the cases share “one or more common questions of fact” and when transfer “will promote the just and efficient conduct of such actions.” A party can ask for it by motion, or the Panel can act on its own.

The statute says each case “shall be remanded” to the district it came from “at or before the conclusion of such pretrial proceedings.” In practice, few are. Of the 1,309,868 civil actions centralized from 1968 through September 30, 2025, the JPML’s fiscal year 2025 report counts 17,678 remanded for trial (1.3%), 1,095,072 ended in the MDL court (83.6%), and 197,118 still pending. Those three add up to the total exactly.

The MDL judge also cannot simply keep a case for trial. The FJC and JPML guide Ten Steps to Better Case Management (2014) says that under Lexecon Inc. v. Milberg Weiss (1998), a transferee judge cannot “self-transfer” an MDL case to their own district to try it. One option the guide gives is to hold bellwether trials in cases first filed in the judge’s own district. It says these “can help promote a global settlement or at least expedite settlement of other individual cases.”

How much of the federal civil docket is in MDLs

About 45% of pending federal civil cases were in MDLs on September 30, 2025:

  • MDL actions pending: 197,118 in 158 MDLs (JPML, fiscal year 2025, as of September 30, 2025).
  • All civil cases pending in US district courts: 432,923 (US Courts, Judicial Business 2025, Table C, as of September 30, 2025). The table’s note says this count “includes cases that have been transferred under a Multidistrict Litigation (MDL) order.”
  • Share: 197,118 / 432,923 = 45.5%.

The two counts come from different reporting systems, so treat the share as approximate.

The MDL caseload is concentrated. The JPML’s pending-MDL report of November 2, 2026 lists 164 active MDLs with 204,987 pending actions. The 20 MDLs with 1,000 or more pending actions hold 193,418 of them, or 94.4%. The three largest on that date:

MDL Litigation Actions pending, Nov. 2, 2026
MDL 2738 Johnson & Johnson Talcum Powder Products 69,376
MDL 2846 Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products 23,299
MDL 2873 Aqueous Film-Forming Foams Products 15,270

MDL 2738 alone held 33.8% of all pending MDL actions on that date (69,376 / 204,987).

Most of these are individual cases filed straight into the MDL court, not cases transferred from elsewhere. In fiscal year 2025, the JPML counted 37,735 actions newly subjected to MDL proceedings; 36,337 of them (96.3%) “were filed directly in transferee districts,” and 1,398 were transferred.

Opting out of a class action

You can opt out of a Rule 23(b)(3) damages class by asking to be excluded by the deadline in the notice; doing nothing keeps you in. Rule 23(c)(2)(B) requires the notice in these cases to tell members “that the court will exclude from the class any member who requests exclusion” and “the time and manner for requesting exclusion.” The judgment then binds everyone who received notice and “who have not requested exclusion” (Rule 23(c)(3)(B)). The rule gives no such exclusion right for classes certified under Rule 23(b)(1) or (b)(2); a (b)(2) class seeks an injunction or a declaration that applies to the class as a whole.

What opting out means, in the FTC’s words: members who opt out “retain the right to participate in a different lawsuit on the same issues, but they do not receive payment in the class action,” and members “who do nothing in response to the notice will automatically become bound by the settlement terms” (FTC staff report, September 2019).

Few people opt out. Across the FTC’s sample of 149 consumer class action settlements, 0.01% of notice recipients excluded themselves, about 1 in 10,000.

Opting out makes most sense when your own loss is large and you can prove it yourself. The Manual for Complex Litigation, quoting the drafters of Rule 23, says the interest in controlling your own case “can be high where the stake of each member bulks large.” For a small loss, the Manual notes, an individual suit may not be a feasible alternative. Before you opt out, ask a lawyer how much time is left to file your own case. Rule 23(e)(4) also lets a court refuse to approve a settlement unless members who passed up an earlier chance to opt out get a new one.

How mass tort settlements are calculated

Large mass tort settlements usually set a value for each claim from its injury and evidence, not one equal share for everyone. The Manual for Complex Litigation (section 22.91) describes the tools courts and parties use:

  • Claimant questionnaires. In some MDL mass torts, courts have ordered claimants to complete questionnaires on “the circumstances of their exposures and the severity of their injuries,” to help settlement talks or claim administration.
  • Comparison with closed cases. Special masters “have sometimes used electronic data to compare individual pending cases against closed cases having similar characteristics to produce a range of settlement values.”
  • Test trials. Parties may “use test-case trials to establish a range of values for resolving similar claims.” These are the bellwether trials described above.
  • Sampling. Parties may resolve a representative sample of claims through mediation or arbitration and use the results “to arrive at a reasonable estimate of the value of the aggregate claims.”
  • A value per claim. A special master can review liability and damages evidence and place “an estimated value on each claim.”

The Manual also cites a settlement built on “a national matrix based on the type of injury”: a grid in which the payment depends on which injury category a claimant proves. The exact categories, point values and lawyer fees differ in every settlement and are set out in that settlement’s own documents.

There is no official average payout for mass tort plaintiffs. The JPML and the Federal Judicial Center do not publish one, and a figure from one settlement says little about another.

Average class action payouts

The best public data on consumer class action payouts is the FTC’s 2019 study of 149 settlements, and it shows small typical payments. In settlements that required a claim:

  • Median compensation was $69. About a quarter of settlements paid a median of $22 or less, and the top quarter paid a median of $200 or more.
  • Few people claim. The median claims rate was 9% of people sent notice; weighted by the number of people notified, it was 4%.
  • Notice method matters. Mailed notice packets had a median claims rate of 16%; email notices had the lowest rates, 2% to 3%.

These are consumer cases only. Securities, antitrust and employment class actions are not in the sample, and their payments can be very different.

Researching a new mass tort

A mass tort’s public record builds up before any MDL exists: FDA adverse-event reports and label changes, clinical trial results, published studies, and the first individual lawsuits. A JPML motion to centralize comes later. In fiscal year 2025, 39 motions to centralize were filed; the Panel granted 19 and denied 14, according to its fiscal year 2025 report. The JPML posts its pending MDLs on its statistics page and in monthly reports.

Hyperresearch can collect the FDA adverse-event, label, clinical trial and published-study record on one product into a single report, with each claim checked against the source it cites. For the trial records themselves, see the ClinicalTrials.gov API guide. To check that a study you rely on has not been withdrawn, see how to check whether a paper is retracted.